BioMed Research International · 2018 · 12 citations · 22 references
MedicineCell BiologyOncologyChemotherapyGynecologic OncologyMetastasisCancer ProgressionCancer Stem Cell BiologyCancer Stem CellsMalignant NeoplasmsOvarian CancerOvarian NeoplasiaCancer Stem Cell MarkersCancer Stem Cell Surface MarkersCell Adhesion ProteinsMalignant Ovarian NeoplasmsMalignant Ovarian TumorsOvarian Cancer ChemotherapyOvarian Cancer MetastasisOvarian Cancer Pathogenesis
Ovarian cancer leads the worst prognosis among all types of gynecologic malignancies, and patients are often diagnosed at an advanced stage. Ovarian cancer also has a high rate of metastasis; however, the detailed mechanisms for ovarian cancer prone to metastasis remain unclear. In this study, we used continuous in vitro screening of the human ovarian cancer A2780 cell line to establish a cell line (A2780-M) which shows high invasiveness and motility. Compared to the parental cells, A2780-M cells express elevated protein levels of CD44, CD133, CD34, and β -catenin. A2780-M cells are also more resistant to chemotherapeutic agents SN-38 and Docetaxel. Thus, the A2780-M cell line is a new ovarian metastatic cancer cell line that expresses tumor stem cell surface markers and adhesion-related membrane proteins and is with higher motility and invasiveness.
22
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Maı̈na Lepourcelet, Ying-Nan P. Chen, Dennis S. France et al. · Cancer Cell · 2004 · 647 citations · Full text